ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $752 | – | 18,982 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,199,011 | $24,629,000 | 3.99% |
| BVF INC/IL | 675,759 | $7,569,000 | 0.91% |
| Orbimed Advisors | 3,298,516 | $36,943,000 | 0.47% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 913,100 | $10,227,000 | 0.40% |
| TIGER MANAGEMENT L.L.C. | 162,728 | $1,823,000 | 0.28% |
| Rock Springs Capital Management LP | 150,000 | $1,680,000 | 0.08% |
| Sowell Financial Services LLC | 15,714 | $168,000 | 0.04% |
| Spark Investment Management LLC | 16,600 | $185,000 | 0.01% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 10,000 | $112,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 38,750 | $434,000 | 0.01% |